Global Mobile Cardiac Telemetry Market

Global Mobile Cardiac Telemetry Market Size, Share, Growth Analysis, By Application(lead based and patch based), By Type(hospitals, cardiac centres and others) - Industry Forecast 2024-2031


Report ID: SQMIG35A2202 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 60 | Figures: 75

Global Mobile Cardiac Telemetry Market Insights

Mobile Cardiac Telemetry Market size was valued at USD 833.8 million in 2019 and is poised to grow from USD 900 million in 2023 to USD 2300 million by 2031, growing at a CAGR of 12.1% in the forecast period (2024-2031).

MCT or MCOT stands for mobile cardiac telemetry systems, and it is the most popular technology in the ambulatory cardiac monitoring sector. The device provides advanced real-time analysis technology and reduces the cost of electrocardiographic diagnosis for outpatients. This is a small portable device that can be taken anywhere. It provides benefits to both the patient and the physician, potentially leading to more efficient care. The rising prevalence of cardiovascular diseases, the benefits of monitoring patients with mobile cardiac telemetry (MCT), and the growing geriatric population are driving the growth of the Mobile Cardiac Telemetry Systems in the healthcare market. Cardiovascular diseases (CVDs) are heart and blood vessel disorders that include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and others. Tobacco use, an unhealthy diet, and physical inactivity, which increases the risk of heart attacks and strokes, are some of the major factors that contribute to death and difficulties. CVDs are the leading cause of death worldwide, affecting more people than any other disease. The mobile cardiac telemetry (MCT) system consists of a small sensor and monitor that patients wear on a daily basis. Whenever a cardiac event occurs, MCT instantly transmits the data to a centre for analysis and response, which then sends a report to the patient's physician along with graphs and trends for diagnosis and therapy management.

US Mobile Cardiac Telemetry Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Mobile Cardiac Telemetry Market size was valued at USD 833.8 million in 2019 and is poised to grow from USD 900 million in 2023 to USD 2300 million by 2031, growing at a CAGR of 12.1% in the forecast period (2024-2031).

The mobile cardiac telemetry system market is highly competitive. To increase market penetration, some of the major industry players are engaging in strategic collaborations, regional expansions, and new product launches. VitalConnect, for example, will launch the VitalPatch RTM mobile cardiac telemetry solution in May 2021. The solution has a versatile and programmable platform that can meet a variety of cardiac monitoring requirements. 'BioTelemetry, Inc.', 'Preventice Solutions', 'iRhythm Technologies Inc.', 'Medicomp Inc.', 'Biotricity Inc.', 'Applied Cardiac Systems Inc.', 'Hill-Rom Holdings Inc.', 'Philips Healthcare', 'Medtronic PLC', 'Zoll Medical Corporation', 'Cardionet Inc.', 'GE Healthcare', 'Welch Allyn Inc.', 'BioTel Heart', 'Infosys Limited', 'Comarch SA', 'Infinium Medical', 'Digi International Inc.', 'Telerhythmics LLC', 'Medic4all Group.'

The increased awareness of emerging patch technology, as well as the introduction of new devices with optimised applications, are driving the growth of the global mobile cardiac telemetry systems market.

Because of the technological advantage, demand for mobile cardiac telemetry systems is expected to grow significantly over the forecast period. Mobile cardiac telemetry systems allow patients to move around and provide physicians with real-time data on their patients.

During the forecast period, North America is expected to dominate the global mobile cardiac telemetry systems market. In the United States, one person dies from cardiovascular disease every 36 seconds. Every year, approximately 659,000 people die from heart disease, accounting for one in every four deaths in the United States. Because of the increasing geriatric population, rising healthcare expenditure, the presence of major service providers with improved healthcare solutions, and the prevalence of cardiac disorders, North America dominates the mobile cardiac telemetry (MCAT) market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Mobile Cardiac Telemetry Market

Product ID: SQMIG35A2202

$5,300
BUY NOW GET FREE SAMPLE